GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,034 | -16.6% | 4,190 | 0.0% | 0.14% | +97.1% |
| Q2 2023 | $249,473 | +5.1% | 4,190 | 0.0% | 0.07% | -17.9% |
| Q1 2023 | $237,322 | -28.0% | 4,190 | -5.6% | 0.08% | -61.5% |
| Q4 2022 | $329,759 | +19.5% | 4,440 | -4.3% | 0.22% | +11.8% |
| Q3 2022 | $276,000 | +6.2% | 4,640 | 0.0% | 0.20% | +27.5% |
| Q2 2022 | $260,000 | -24.0% | 4,640 | 0.0% | 0.15% | -11.0% |
| Q1 2022 | $342,000 | -16.6% | 4,640 | -18.3% | 0.17% | -12.7% |
| Q4 2021 | $410,000 | -5.7% | 5,680 | 0.0% | 0.20% | +39.7% |
| Q3 2021 | $435,000 | -1.1% | 5,680 | 0.0% | 0.14% | +17.5% |
| Q2 2021 | $440,000 | +15.5% | 5,680 | -8.1% | 0.12% | +10.1% |
| Q1 2021 | $381,000 | +36.6% | 6,180 | +44.4% | 0.11% | +34.6% |
| Q4 2020 | $279,000 | -13.9% | 4,280 | -34.7% | 0.08% | -21.4% |
| Q3 2020 | $324,000 | – | 6,550 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |